The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
Altered Hox expression and segmental identity in Mll-mutant mice
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 875
hDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
Transitions in Distinct Histone H3 Methylation Patterns at the Heterochromatin Domain Boundaries
Noma, K.-I., Allis, C. D., & Grewal, S. I. S. (2001) · Science · doi:10.1126/science.1064150 · Cited by 747
Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C. M., & Canaani, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00740-2 · Cited by 721
Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., & Cleary, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5639-5649.2004 · Cited by 662
Self-citationMenin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus
Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00081-4 · Cited by 645
Self-citationHoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription
Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80967-8 · Cited by 627
Strahl, B. D., Ohba, R., Cook, R. G., & Allis, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14967 · Cited by 491
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1118 · Cited by 472
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
Milne, T. A., Hughes, C. M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R. W., Krankel, C., LiVolsi, V. A., Gibbs, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408836102 · Cited by 469
Self-citationTransformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 436
Self-citationLavau, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4226 · Cited by 400
MLL: a histone methyltransferase disrupted in leukemia
Hess, J. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.005 · Cited by 360
Weinmann, A. S., & Farnham, P. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00006-3 · Cited by 345
Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
Zeisig, B. B., Milne, T., García-Cuéllar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.617-628.2004 · Cited by 328
Yu, B. D., Hanson, R. D., Hess, J. L., Horning, S. E., & Korsmeyer, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10632 · Cited by 302
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
Definitive Hematopoiesis Requires the Mixed-Lineage Leukemia Gene
Ernst, P., Fisher, J. K., Avery, W., Wade, S., Foy, D., & Korsmeyer, S. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00061-9 · Cited by 265
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies
DiMartino, J. F., & Cleary, M. L. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01439.x · Cited by 259
Self-citationDefects in Yolk Sac Hematopoiesis in Mll-Null Embryos
Hess, J. L., Yu, B. D., Li, B., Hanson, R., & Korsmeyer, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1799 · Cited by 257
Bertolino, P., Tong, W.-M., Galendo, D., Wang, Z.-Q., & Zhang, C.-X. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0154 · Cited by 255
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., & Komori, T. (1998) · Blood · doi:10.1182/blood.v92.1.108.413k11_108_117 · Cited by 238
Wright, D. E., Cheshier, S. H., Wagers, A. J., Randall, T. D., Christensen, J. L., & Weissman, I. L. (2001) · Blood · doi:10.1182/blood.v97.8.2278 · Cited by 208
So, C. W., Karsunky, H., Passegué, E., Cozzio, A., Weissman, I. L., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00019-9 · Cited by 204
Self-citationUpregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality
Rozovskaia, T., Feinstein, E., Mor, O., Foa, R., Blechman, J., Nakamura, T., Croce, C. M., Cimino, G., & Canaani, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204174 · Cited by 181
An Mll-Dependent Hox Program Drives Hematopoietic Progenitor Expansion
Ernst, P., Mabon, M., Davidson, A. J., Zon, L. I., & Korsmeyer, S. J. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.012 · Cited by 179
HOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis
Owens, B. M., & Hawley, R. G. (2002) · STEM CELLS · doi:10.1634/stemcells.20-5-364 · Cited by 166
Kim, H., Lee, J., Cho, E., Liu, J. O., & Youn, H. (2003) · PubMed · Cited by 165
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis
Daser, A., & Rabbitts, T. H. (2004) · Genes & Development · doi:10.1101/gad.1195504 · Cited by 163
Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., & Ohki, M. (2002) · Blood · doi:10.1182/blood-2002-04-1015 · Cited by 162
Self-citationLeukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9
So, C. W., Karsunky, H., Wong, P., Weissman, I. L., & Cleary, M. L. (2004) · Blood · doi:10.1182/blood-2003-10-3722 · Cited by 160
Self-citationThe AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
DiMartino, J. F., Ayton, P. M., Chen, E. H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3780 · Cited by 137
Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter
Agarwal, S. K., Novotny, E. A., Crabtree, J. S., Weitzman, J. B., Yaniv, M., Burns, A. L., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., & Marx, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834524100 · Cited by 136
Schnabel, C. A., Jacobs, Y., & Cleary, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203371 · Cited by 134
Self-citationHoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia
Kumar, A. R., Hudson, W. A., Chen, W., Nishiuchi, R., Yao, Q., & Kersey, J. H. (2003) · Blood · doi:10.1182/blood-2003-07-2582 · Cited by 130
Conditional MLL‐CBP targets GMP and models therapy‐related myeloproliferative disease
Wang, J., Iwasaki, H., Krivtsov, A. V., Febbo, P. G., Thorner, A. R., Ernst, P., Anastasiadou, E., Kutok, J. L., Kogan, S. C., Zinkel, S. S., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600521 · Cited by 115
Huntsman, D. D., Chin, S., Muleris, M., Batley, S. J., Collins, V. P., Wiedemann, L. M., Aparicio, S. A. J. R., & Caldas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203291 · Cited by 107
Nie, Z., Yan, Z., Chen, E. H., Sechi, S., Ling, C., Zhou, S., Xue, Y., Yang, D., Murray, D., Kanakubo, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2942-2952.2003 · Cited by 88
Self-citationFunctional studies of the MEN1 gene
Chandrasekharappa, S. C., & Teh, B. T. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01165.x · Cited by 71
Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice.
Verlinden, S. F. F., van Es, H. H. G., & van Bekkum, D. W. (1998) · PubMed · Cited by 62
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 58
The biological and clinical significance of MLL abnormalities in haematological malignancies
Mitterbauer‐Hohendanner, G., & Mannhalter, C. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.0960-135x.2004.01366.x · Cited by 33
Caldas, C., Kim, M.-H., MacGregor, A., Cain, D., Aparicio, S. A. J. R., & Wiedemann, L. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201873 · Cited by 32
Cited by
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Regulation of MLL1 H3K4 methyltransferase activity by its core components
Dou, Y., Milne, T. A., Ruthenburg, A. J., Lee, S., Lee, J. W., Verdine, G. L., Allis, C. D., & Roeder, R. G. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1128 · Cited by 763
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rao, R. C., & Dou, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3929 · Cited by 669
Metadata
- Authors
- Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt-Rosen, O., Meyerson, M., & Cleary, M. L.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 123
- Issue
- 2
- Pages
- 207-218
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2154218976
- Cited by
- 688
- References
- 48
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.